Cibus Global LLC (NASDAQ:CBUS) — Market Cap & Net Worth
Market Cap & Net Worth: Cibus Global LLC (CBUS)
Cibus Global LLC (NASDAQ:CBUS) has a market capitalization of $101.83 Million ($101.83 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19117 globally and #4203 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cibus Global LLC's stock price $1.45 by its total outstanding shares 76172866 (76.17 Million). Analyse CBUS cash flow conversion to see how efficiently the company converts income to cash.
Cibus Global LLC Market Cap History: 2017 to 2026
Cibus Global LLC's market capitalization history from 2017 to 2026. Data shows change from $83.90 Billion to $110.45 Million (-49.26% CAGR).
Index Memberships
Cibus Global LLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1868 of 3165 |
Weight: Cibus Global LLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cibus Global LLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cibus Global LLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
36.42x
Cibus Global LLC's market cap is 36.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $83.90 Billion | $508.00K | -$25.98 Million | 165166.17x | N/A |
| 2018 | $39.46 Billion | $236.00K | -$27.90 Million | 167192.99x | N/A |
| 2019 | $26.70 Billion | $7.30 Million | -$39.61 Million | 3659.35x | N/A |
| 2020 | $16.07 Billion | $23.85 Million | -$44.84 Million | 673.87x | N/A |
| 2021 | $8.11 Billion | $25.99 Million | -$29.20 Million | 312.17x | N/A |
| 2022 | $563.68 Million | $157.00K | -$16.89 Million | 3590.31x | N/A |
| 2023 | $1.50 Billion | $1.82 Million | -$267.63 Million | 823.35x | N/A |
| 2024 | $211.76 Million | $4.26 Million | -$251.39 Million | 49.69x | N/A |
| 2025 | $132.54 Million | $3.64 Million | -$127.08 Million | 36.42x | N/A |
Competitor Companies of CBUS by Market Capitalization
Companies near Cibus Global LLC in the global market cap rankings as of May 4, 2026.
Key companies related to Cibus Global LLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Cibus Global LLC Historical Marketcap From 2017 to 2026
Between 2017 and today, Cibus Global LLC's market cap moved from $83.90 Billion to $ 110.45 Million, with a yearly change of -49.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $110.45 Million | -16.67% |
| 2025 | $132.54 Million | -37.41% |
| 2024 | $211.76 Million | -85.85% |
| 2023 | $1.50 Billion | +165.41% |
| 2022 | $563.68 Million | -93.05% |
| 2021 | $8.11 Billion | -49.53% |
| 2020 | $16.07 Billion | -39.80% |
| 2019 | $26.70 Billion | -32.34% |
| 2018 | $39.46 Billion | -52.97% |
| 2017 | $83.90 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Cibus Global LLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $101.83 Million USD |
| MoneyControl | $101.83 Million USD |
| MarketWatch | $101.83 Million USD |
| marketcap.company | $101.83 Million USD |
| Reuters | $101.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cibus Global LLC
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more